Clinical Trials for the week of September 18

Clinical Trials of interest to cytokine & interferon researchers. Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT ClinicalTrials.gov ID NCT06130579 Sponsor: Peking University People’s Hospital Information provided by Xiao-Jun Huang, Peking University People’s Hospital (Responsible Party) Last Update Posted 2024-03-21 MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera (MITHRIDATE) ClinicalTrials.gov ID NCT04116502 Sponsor: University of Birmingham Information provided by University of Birmingham (Responsible Party) Last Update Posted 2024-05-10 Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression (IPOS) ClinicalTrials.gov ID NCT04798612 Sponsor: Zealand University Hospital Information provided by Zealand University Hospital (Responsible Party) Last Update Posted 2023-08-18